ADVERTISEMENT
The Moment Nigeria
  • Home
  • News
  • Business
  • Entertainment
  • Interviews
  • Life and Styles
  • Sport
No Result
View All Result
  • Home
  • News
  • Business
  • Entertainment
  • Interviews
  • Life and Styles
  • Sport
No Result
View All Result
The Moment Nigeria
No Result
View All Result
  • Home
  • News
  • Business
  • Entertainment
  • Interviews
  • Life and Styles
  • Sport

AltBank unveils non-interest financing to boost local drug production

by Honesty Victor
May 12, 2026
Reading Time: 2 mins read
AltBank unveils non-interest financing to boost local drug production
Share on FacebookShare on TwitterShare on WhatsappShare on LinkedIn

Against the backdrop of Africa’s heavy dependence on imported medicines, The Alternative Bank has intensified efforts to support local pharmaceutical manufacturing in Nigeria through specialised non interest financing targeted at industrial pharmacists and healthcare operators.

The move comes as Africa continues to bear about 25 per cent of the global disease burden while importing nearly 97 per cent of its pharmaceutical products, a situation that exposed the continent’s vulnerability during the COVID-19 pandemic.

Speaking in an interview with the National Association of Industrial Pharmacists of Nigeria, NAIP, for the maiden edition of its Pharma Industry Digest, Jekwu Ozoemene said strengthening local pharmaceutical production has become critical to Nigeria’s healthcare security and economic survival.

RELATED STORIES

Nigeria @ 65: “We Are Not Better, Our Independence Is Like Bondage” – Primate Ayodele

Primate Ayodele makes shocking revelation ahead of Tinubu’s 2027 Re-election

May 12, 2026
US spends $12 bn on Iran war in just two weeks

Iran war: Trump to suspend US gas tax

May 12, 2026

According to him, the bank is positioning itself as a strategic financing partner for players across the pharmaceutical value chain through asset-backed and risk-sharing financing structures designed to support sustainable growth.

“Pharma and medicine security and sovereignty is essential to Nigeria’s survival. We are positioned to partner with all stakeholders to make this a reality,” he said.

He explained that unlike conventional lending models, the bank aligns repayment obligations with the actual cash flow of businesses, thereby reducing pressure on manufacturers and distributors.

Ozoemene disclosed that the bank has introduced healthcare-focused financing products nationwide, including stock financing, vendor and distributor financing, revolving drug funds and supply chain financing.

He added that the bank is also supporting broader healthcare reforms through health insurance schemes, health management information systems, Banking-as-a-Service platforms and capital market access initiatives in collaboration with State Health Boards.

“We don’t only want to finance the company that imports the most products. We also want to finance.

industrial pharmacists establishing WHO-compliant manufacturing plants to produce essential medicines locally,” he added.

Next Post
Transcorp shareholders get N29.3 bn dividend

Transcorp shareholders get N29.3 bn dividend

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

STANBIC IBTC ADVERT

About Us

Themomentng.com is an online community of reporters and social advocates dedicated to bringing you features, news reports by Africans, but from a global perspective.

Contact Us

+447771081433
+2348051966180(WhatsApp/SMS Only)
Email: themomentng@gmail.com

Categories

  • Business
  • Education
  • Entertainment
  • Events
  • Featured
  • Food
  • Foreign
  • Health
  • Interviews
  • Life and Styles
  • Metro
  • Motoring
  • News
  • Opinion
  • Politics
  • Religion
  • Society
  • Sport
  • Technology
  • Top Story

Follow Us

Facebook Twitter Instagram

Copyright © Themomentng.com. All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Business
  • Entertainment
  • Interviews
  • Life and Styles
  • Sport